The prevalence of GP Mur and anti-"Mia" in a tertiary hospital in Peninsula Malaysia

Prathiba, Ramesh, and Lopez, C.G., and Usin, F. Mary, (2002) The prevalence of GP Mur and anti-"Mia" in a tertiary hospital in Peninsula Malaysia. Malaysian Journal of Pathology, 24 (2). pp. 95-98. ISSN 0126-8635

Preview

PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
129Kb

Affiliations

University of Malaya Medical Centre, Transfusion Medical Unit
University of Malaya Medical Centre, Transfusion Medical Unit
University of Malaya Medical Centre, Transfusion Medical Unit

Abstract

The Mi I11 phenotype of the Miltenberger subsystem (or GP Mur) is relatively common in Southeast Asia especially along the south-east coast lines of China and Taiwan. The term anti-"Mia" describes antibodies that react with the Mi I11 phenotype. Since the Peninsula Malaysian population is a multiethnic one with a significant proportion of Chinese, a study was conducted into the prevalence of anti-"Mia" in patients from its 3 major ethnic groups - Chinese, Malays and Indians, as well as the GP Mur phenotype in blood donors (healthy individuals). Blood samples from 33,7 16 patients (general and antenatal) were screened for anti-"MP" from January 1999 to December 2000. The investigation for the GP Mur phenotype representing the corresponding sensitizing antigen complex was carried out in 655 blood donors. Serum anti-"Mia" antibody was found to be the third most commonly occurring antibody detected in our patients and was found in all the ethnic groups. The antibody was detected in 0.2% of 33,7 16 antenatal and general patients with a prevalence in Chinese of 0.3%, Malay 0.2% and Indian 0.2%. The detection of these antibodies in the ethnic groups other than the Chinese is a noteworthy finding as such information is not well documented. The GP Mur red cell phenotype was detected in 151306(4.9%) of Chinese blood donors, a lower prevalence than in Chinese populations in other countries in the region. More significant was its detection in the Malays (2.8%) and the Indians (3.0%). Because of the many reports of clinical problems associated with the "MP" antibody including the causation of fetal hydrops and haemolytic transfusion reactions, it is warranted that the GP Mur red cells be included in screening panels for group and screen procedures in countries with a significant Asian population.

Item Type:

Journal

Additional Information:

We are indebted to Mr. Sukumaran for his help in data collection and to En. Mohd Zaki for some of the technical work.

Keywords:

GP Mur phenotype, anti-"Mi a ", ethnic groups, Malaysians

Subjects:

R Medicine, Dentistry, Pharmacy, Nursing

ID Code:

1817